EVP, Chief Financial Officer
Thu, Jun 11, 2026
Jun 11
106,563 shares @ $34.10
Decreased holdings by -61.90%
3rd largest trade (out of 58)
Planned (10b5-1)Large Trade
“The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 22% above 200-day moving average
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—